• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

剂量反应血小板聚集测定法中的方法。

Methods in dose response platelet aggregometry.

作者信息

Thompson S G, Vickers M V

出版信息

Thromb Haemost. 1985 Apr 22;53(2):216-8.

PMID:4024031
Abstract

A standardized method for performing dose response platelet aggregation has been developed, and has been used in about 1000 subjects in a large prospective study of ischaemic heart disease. A computer program has been used to fit a sigmoidal relationship between primary aggregation response rate and the log dose of aggregating reagent. Estimates of the parameters of the sigmoid curve are used to characterize an individual's platelet aggregability. Methods for investigating the maintenance of long-term quality control have also been developed.

摘要

已经开发出一种用于进行剂量反应血小板聚集的标准化方法,并已在一项关于缺血性心脏病的大型前瞻性研究中应用于约1000名受试者。已使用计算机程序来拟合初级聚集反应率与聚集试剂对数剂量之间的S形关系。S形曲线参数的估计值用于表征个体的血小板聚集能力。还开发了用于研究长期质量控制维持情况的方法。

相似文献

1
Methods in dose response platelet aggregometry.剂量反应血小板聚集测定法中的方法。
Thromb Haemost. 1985 Apr 22;53(2):216-8.
2
Sources of variability in dose response platelet aggregometry.
Thromb Haemost. 1985 Apr 22;53(2):219-20.
3
Comparison of platelet aggregation using light transmission and multiple electrode aggregometry in Glanzmann thrombasthenia.在血小板无力症中使用光透射法和多电极聚集测定法比较血小板聚集情况。
Platelets. 2009 Aug;20(5):297-301. doi: 10.1080/09537100903006246.
4
Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.在评估血小板ADP P2Y12受体抑制作用时,VASP磷酸化检测与光透射聚集法的比较。
Thromb Haemost. 2006 Dec;96(6):767-73.
5
Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.评估低至中等剂量阿司匹林在缺血性卒中和短暂性脑缺血发作早期及晚期的抗血小板作用。
Platelets. 2005 Aug;16(5):269-80. doi: 10.1080/09537100400020567.
6
Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.阿司匹林对血小板功能剂量相关效应的评估:阿司匹林诱导血小板效应(ASPECT)研究结果
Circulation. 2007 Jun 26;115(25):3156-64. doi: 10.1161/CIRCULATIONAHA.106.675587. Epub 2007 Jun 11.
7
Testing agonist-induced platelet aggregation by the Impact-R [Cone and plate(let) analyzer (CPA)].使用Impact-R[锥板(血小板)分析仪(CPA)]检测激动剂诱导的血小板聚集。
Platelets. 2008 Sep;19(6):440-6. doi: 10.1080/09537100802082256.
8
Effect of sex difference on platelet aggregation using an optical method in healthy subjects.采用光学方法研究健康受试者性别差异对血小板聚集的影响。
Clin Lab Haematol. 2006 Feb;28(1):14-6. doi: 10.1111/j.1365-2257.2006.00742.x.
9
Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study.高剂量氯吡格雷维持治疗对择期经皮冠状动脉介入治疗患者的功能影响:一项随机研究的结果
Thromb Haemost. 2008 Jan;99(1):161-8. doi: 10.1160/TH07-09-0562.
10
[Action of aminoglycosides on platelet aggregation in vitro].[氨基糖苷类抗生素对体外血小板聚集的作用]
Boll Soc Ital Biol Sper. 1985 Mar 30;61(3):357-63.

引用本文的文献

1
Anti-Inflammatory and Antiplatelet Interactions on PAF and ADP Pathways of NSAIDs, Analgesic and Antihypertensive Drugs for Cardioprotection-In Vitro Assessment in Human Platelets.非甾体抗炎药、镇痛药及抗高血压药对血小板活化因子(PAF)和二磷酸腺苷(ADP)途径的抗炎及抗血小板相互作用——人体血小板的体外评估用于心脏保护
Medicina (Kaunas). 2025 Aug 4;61(8):1413. doi: 10.3390/medicina61081413.
2
Palmolein and groundnut oil have comparable effects on blood lipids and platelet aggregation in healthy Indian subjects.在健康的印度受试者中,棕榈油精和花生油对血脂及血小板聚集有相似的影响。
Lipids. 1995 Dec;30(12):1163-9. doi: 10.1007/BF02536619.
3
Inhibition of thrombocyte aggregation by oral motapizone and other drugs.
Eur J Clin Pharmacol. 1986;31(4):411-4. doi: 10.1007/BF00613515.
4
Hypotensive and antiplatelet actions of motapizone depend on dose and time after ingestion.
Eur J Clin Pharmacol. 1986;31(4):405-10. doi: 10.1007/BF00613514.